TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
FBRX

Forte Biosciences Inc

Healthcare · Biotechnology

77.00$ +0.0% vs. previous close Closing price · As of: Aug 28, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement FBRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.05 0.93 1.05 13.49 0.43 0.00 0.00 0.00 0.00 0.00 0.00
– – – – 0.13 0.18 0.06 – 0.01 0.01 0.00
1.05 0.93 1.05 13.49 -0.13 -0.18 -0.06 – -0.01 -0.01 0.00
394.27 516.10 747.39 37.73 31.70 33.80 24.79 8.04 17.31 7.27 3.96
78.83 85.74 219.67 0.20 16.37 14.34 13.66 11.94 8.41 5.28 0.84
468.33 597.01 959.57 47.30 48.06 48.14 38.46 19.98 25.72 12.54 4.80
-472.05 -600.91 -966.01 -34.29 -48.19 -48.33 -38.46 -19.98 -25.72 -12.55 -4.80
2.10 34.83 49.60 0.13 45.30 0.00 0.40 0.02 – – –
-474.15 -634.80 -999.38 -35.34 -48.25 -157.93 -38.85 -19.96 -24.92 -12.17 -4.64
-4.20 -69.67 -66.75 1.27 -0.03 108.91 -0.36 -0.02 – -12.17 0.07
-474.15 -634.80 -999.38 -36.61 -48.25 -157.93 -38.85 -19.94 -24.92 -12.17 -4.71
-462.41 -591.05 -942.29 -32.67 -48.12 -157.74 -38.79 -19.98 -24.92 -12.15 -4.64

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?